Pfizer

Pfizer acquires Icagen

Wednesday, July 20, 2011 01:57 PM

Pfizer and Icagen have entered into a definitive merger agreement. Pfizer, which currently owns approximately 11% of Icagen’s fully diluted shares, will acquire the remaining 8.3 million shares at a price of $6 per share. The aggregate transaction value, including the value of the shares currently owned by Pfizer, is approximately $56 million.

More... »

PPD shares rise on takeover rumors

Monday, July 18, 2011 01:51 PM

Shares of CRO Pharmaceutical Product Development (PPD) rose 16% to levels not touched in more than two-and-a-half years on Monday, a day after a Wall Street Journal report said the company was looking to sell itself, reported Reuters.

More... »

DVS Sciences raises $14.6 million

Friday, July 15, 2011 10:58 AM

The Ontario Institute for Cancer Research (OICR) and DVS Sciences have announced DVS Sciences has completed a $14.6 million series A financing. DVS, a Toronto-based spinoff from the University of Toronto, invented and manufactures instrumentation that enables paradigm-shifting biological research with potential clinical applications that include personalized medicine.

More... »

FDA proposes targeted drug testing guidelines

Wednesday, July 13, 2011 10:53 AM

Targeted drugs or therapies up for regulatory approval would have to be reviewed simultaneously with the diagnostic devices they rely on, according to a proposed policy issued by the FDA, according to Reuters.

More... »

FDA eases rules for Alzheimer’s experiments to speed new treatments for dementia

Tuesday, July 12, 2011 12:35 PM

The FDA is making it easier to test new Alzheimer’s drugs, hoping to speed progress toward new treatments for the mind-robbing disease, according to an Associated Press report.

More... »

Study brokers Interspond, Elias Research head to court over alleged trade secret violations

Monday, July 11, 2011 08:02 AM

Two trial management firms (TMOs), known more commonly in the industry as study brokers, have taken their disagreement to court.

More... »

Lilly pitches plan to overcome key patent losses

Friday, July 8, 2011 10:15 AM

Eli Lilly, only months away from losing patent protection for its top-selling drug, told investors the keys to overcoming this and other patent losses lie in its labs and emerging markets including China, according to Mercury News.

More... »

Pfizer seeking alternatives for Animal Health and Nutrition businesses

Friday, July 8, 2011 10:04 AM

Pfizer is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value.

More... »

Former Pfizer research chief wary of R&D strategy

Thursday, July 7, 2011 10:02 AM

Pfizer may have won over shareholders with its recent decision to pare back R&D spending, but it could be shortchanging them in the long run, Pfizer’s former research chief told Reuters.

More... »

Pfizer collaborates on drugs for Russian market

Friday, July 1, 2011 10:08 AM

Pfizer will work with a Russian venture capital company to research and market new drugs in Russia and surrounding countries, according to the Associated Press.

More... »